| Hot-Stocks Übersicht |
| SONO GROUP Aktie | +70,68% |
| GOPRO Aktie | +69,76% |
| SQUARE ENIX Aktie | +9,49% |
| DORMAKABA Aktie | +5,21% |
| NOVARTIS Aktie | +4,93% |
| HUT 8 Aktie | +4,24% |
| AIR LIQUIDE Aktie | +4,21% |
| TOYOTA Aktie | +3,88% |
| TCL Aktie | +3,84% |
| ASTELLAS Aktie | +3,15% |
| ARIZONA GOLD Aktie | +3,06% |
| NISSAN MOTOR Aktie | +2,60% |
| PLANETHIC Aktie | +2,59% |
| STRABAG Aktie | +2,44% |
| SONY Aktie | +2,28% |
| SAMSUNG VZ Aktie | +2,24% |
| NUREXONE Aktie | +2,23% |
| MEDTRONIC Aktie | +2,20% |
| INFINEON Aktie | +2,13% |
| LABCORP Aktie | +2,08% |
| BYD Aktie | +2,07% |
| MINISO Aktie | -2,09% |
| RENK Aktie | -2,14% |
| RHEINMETALL Aktie | -2,24% |
| INNOCAN Aktie | -2,38% |
| MEITUAN Aktie | -2,77% |
| AKESO Aktie | -3,12% |
| NIO ADR Aktie | -6,54% |
| OHB Aktie | -7,43% |
| PARTNERS GROUP Aktie | -7,68% |
| OCUGEN INC. DL-,001 |
| USA |
| Gesundheit |
| US67577C1053 / A2PSZH |
| 2H51 (Frankfurt) / OCGN (NASDAQ) |
| FRA:2H51, ETR:2H51, 2H51:GR, NASDAQ:OCGN |
| - |
| https://ocugen.com/ |
|
Ocugen Inc. is a clinical-stage biopharmaceutical company focused on developing gene and cell therapies for blindness diseases and other serious ocular conditions. Its current programs center on a modifier gene therapy platform designed to address in..
>Volltext.. |
| 401.05 Mio. EUR |
| 390.42 Mio. EUR |
| 3.95 Mio. EUR |
| -57.99 Mio. EUR |
| -70.62 Mio. EUR |
| -0.22 EUR |
| 75.95 Mio. EUR |
| 86.37 Mio. EUR |
| -52.54 Mio. EUR |
| 0.75 |
| -0.63% |
| -48.2% |
| - |
| - |
| - |
| - |
| OCUGEN |
| 01.09.26 |
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
